I would like to discuss a proposal to address a clinical practice guideline in screening for breast cancer in women with an average risk that is supported by the Agency for Healthcare Research and Quality (AHRQ). AHRQ a federal agency working under the U.S. Department of Health and Human Services, which provides comprehensive and science-based information on improving the quality of healthcare. A). The following guidelines were reviewed:
1. American College of Obstetricians and Gynecologists. (ACOG). Breast cancer screening. American College of Obstetricians and Gynecologists (ACOG); 2011 Aug. 11 p. (ACOG practice bulletin; no. 122)
2. Canadian Task Force on Preventive Health Care (CTFPHC). Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011 Nov 22; 183 (17): 1991-2001.
3. Kaiser Permanente Care Management Institute (KPCMI). Breast cancer screening clinical practice guideline. Oakland (CA): Kaiser Permanent Care Management Institute; 2010 Aug. 142p.
B). Evaluation of the areas of agreement and difference
1. Areas of agreement:
a). According to ACOG (2011), it is not recommended to mammography screen women greater than 74 years of age, due to limited benefit in reduction of life expectancy and lack of available data to support screening in women greater than 74.
b). For …show more content…
b). MRI testing by the CTFPHC (2011) offer weak recommendations for asymptomatic women at average risk for breast cancer and KPCMI (2010) offer only consensus-based based on asymptomatic women as well. c). Clinical breast examination (CBE) recommendations from ACOG (2011) provides level C evidence to perform clinical annual breast exams for women aged 40 and older and for women aged 20-39 to perform CBE’s every 1-3 years. CTFPHC (2011) found no evidence for women to perform CBE or breast self-examination in reducing mortality due to breast
1. American College of Obstetricians and Gynecologists. (ACOG). Breast cancer screening. American College of Obstetricians and Gynecologists (ACOG); 2011 Aug. 11 p. (ACOG practice bulletin; no. 122)
2. Canadian Task Force on Preventive Health Care (CTFPHC). Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011 Nov 22; 183 (17): 1991-2001.
3. Kaiser Permanente Care Management Institute (KPCMI). Breast cancer screening clinical practice guideline. Oakland (CA): Kaiser Permanent Care Management Institute; 2010 Aug. 142p.
B). Evaluation of the areas of agreement and difference
1. Areas of agreement:
a). According to ACOG (2011), it is not recommended to mammography screen women greater than 74 years of age, due to limited benefit in reduction of life expectancy and lack of available data to support screening in women greater than 74.
b). For …show more content…
b). MRI testing by the CTFPHC (2011) offer weak recommendations for asymptomatic women at average risk for breast cancer and KPCMI (2010) offer only consensus-based based on asymptomatic women as well. c). Clinical breast examination (CBE) recommendations from ACOG (2011) provides level C evidence to perform clinical annual breast exams for women aged 40 and older and for women aged 20-39 to perform CBE’s every 1-3 years. CTFPHC (2011) found no evidence for women to perform CBE or breast self-examination in reducing mortality due to breast